Narrow search
Showing 21 - 30 of 27,214
Cover Image
China Policies to Promote Local Production of Pharmaceutical Products and Protect Public Health
Abbott, Frederick M. - 2017
Persistent link: https://www.econbiz.de/10012956982
Cover Image
Indian Policies to Promote Local Production of Pharmaceutical Products and Protect Public Health
Abbott, Frederick M. - 2017
Persistent link: https://www.econbiz.de/10012957025
Cover Image
Drugs on Tap : Managing Pharmaceuticals in Our Nation's Waters
Eckstein, Gabriel - 2018
Pharmaceuticals in the environment and public water supplies are believed to have serious impacts on human and … human health effects. Other studies more conclusively show that even minute concentrations of pharmaceuticals in the … awareness about the lack of governmental attention to the growing problem pharmaceuticals and pharmaceutical residues pose to …
Persistent link: https://www.econbiz.de/10012937158
Cover Image
The Patent Buyout Price for Human Papilloma Virus (HPV) Vaccine and the Ratio of R&D Costs to the Patent Value
Songane, Mario - 2020
Human papillomavirus (HPV) is responsible for almost all of the 570,000 new cases of cervical cancer and approximately 311,000 deaths per year. HPV vaccination is an integral component of the World Health Organization's (WHO) global strategy to fight the disease. However, high vaccine prices...
Persistent link: https://www.econbiz.de/10012825394
Cover Image
State Pharmaceutical Importation Programs : An Analysis of the Cost Effectiveness
Acri née Lybecker, Kristina M.L. - 2019
West Virginia aims to reduce spending on pharmaceuticals by importing them from Canada. To examine the cost effectiveness …
Persistent link: https://www.econbiz.de/10012868596
Cover Image
Pharmaceutical Antitrust : What the Trump Administration Can Do
Carrier, Michael A. - 2016
Drug prices are in the news. “Pharma Bro” Martin Shkreli increased the price of Daraprim, a treatment for fatal parasitic infections, by 5000%. Mylan found itself on the hot seat for raising the price of the anaphylaxis-treating EpiPen 15 times in 7 years, resulting in a 400% increase to...
Persistent link: https://www.econbiz.de/10012978113
Cover Image
2008 and 2015 : Night and Day for Drug Patent Settlements
Carrier, Michael A. - 2015
A lot changed between 2008 and 2015. Lindsay McSweeney's stewardship cemented the importance of CPI Antitrust Chronicle. Standard-essential patents, the smartphone patent wars, and patent trolls thrust themselves onto the IP/antitrust scene. But perhaps the most significant change is the...
Persistent link: https://www.econbiz.de/10013010245
Cover Image
Price Regulation and Parallel Imports of Pharmaceuticals
Brekke, Kurt Richard - 2015
This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a theory model where the producer price is subject to bargaining between the brand-name producer and a distributor, we show that the effects of stricter price regulation crucially...
Persistent link: https://www.econbiz.de/10013017702
Cover Image
Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform
Brekke, Kurt Richard - 2015
In this paper we study the impact of reference pricing (RP) on entry of generic firms in the pharmaceutical market. For given prices, RP increases generic firms' expected profit, but since RP also stimulates price competition, the impact on generic entry is theoretically ambiguous. In order to...
Persistent link: https://www.econbiz.de/10013021208
Cover Image
No Shot : US Vaccine Prices and Shortages
Ridley, David B. - 2016
In 2004 an Institute of Medicine report warned of vaccine shortages, raising concerns about disease outbreaks. More than a decade later, we looked for progress in reducing vaccine shortages. We analyzed data on vaccine sales and shortages reported by practitioners and patients to the Food and...
Persistent link: https://www.econbiz.de/10012994717